Javascript must be enabled to continue!
Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
View through CrossRef
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
Purpose
Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).
Material and method
Between 01.01.2016–31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.
Results
Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (p = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%, p <0.001).
Conclusions
The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
Title: Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
Description:
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
Purpose
Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).
Material and method
Between 01.
01.
2016–31.
03.
2018, we performed a prospective study including 656 patients with STEMI.
We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.
Results
Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died.
Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.
9% vs.
14.
3%).
The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (p = 0.
039).
Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.
33% vs.
1.
75%, p <0.
001).
Conclusions
The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon.
Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
Related Results
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Objectives
This study was to investigate the safety and efficacy of thrombolysis followed by early PCI via transradial artery approach in patients with ST-segment...
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Background: Recently, many hospitals in Yemen have been started using Percutaneous Coronary Intervention (PCI) procedure for treatment coronary artery disease (CAD), including Dr. ...
e0643 Effects of no-reflow phenomenon identified by myocardial blush grades on systolic function and synchrony in patients with acute myocardial infarction after PCI
e0643 Effects of no-reflow phenomenon identified by myocardial blush grades on systolic function and synchrony in patients with acute myocardial infarction after PCI
Objective
To investigate the effect of no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
...
Solder Reflow Method and Reflow Temperature Profile
Solder Reflow Method and Reflow Temperature Profile
ABSTRACT
The major cause of integrated circuit package failure mechanisms such as delamination, internal cracking or popcorning is package saturation with moistur...
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Objective
Percutaneous Coronary Intervention (PCI) is a technique of cardiac intervention treatment in revascularisation of coronary vessel. The use of PCI in pat...
e0540 Efficacy and safety of tirofiban-assisted Delayed PCI in Patients with ST-segment elavation myocardial infarction
e0540 Efficacy and safety of tirofiban-assisted Delayed PCI in Patients with ST-segment elavation myocardial infarction
Objective
To compare the outcomes of IIb/IIIa antagonist assisted PCI within 12–72 h of onset with that of selective PCI within 7–10 days in STEMI patients.
...
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
Objectives
The Novel approaches for preventing or limiting events (NAPLIES) and The Atorvastatin for Reduction of Myocardial Damage during Angioplasty (ARMYDA) st...
GW24-e3153 Safety and feasibility of early transradial interventional treatment after successful thrombolysis
GW24-e3153 Safety and feasibility of early transradial interventional treatment after successful thrombolysis
Objectives
The goal of this study was to evaluate the safety and feasibility of early angioplasty within 12 hours and selective angioplasty 1 week later after suc...

